Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, we focus on Valeo Pharma (VPH.C), in this revisit, we talk about the Canadian specialty pharma company’s recent wins, stock run and why they deserve a good hard look as a potential part of your investment portfolio.

Enjoy!